Neutralizing Antibodies to SARS‐CoV‐2 Variants of Concern Including Delta and Omicron in Subjects Receiving Mrna‐1273, BNT162b2, and Ad26.COV2.S Vaccines
Journal of Medical Virology（2022）
Key words
COVID-19,neutralizing antibodies,SARS-CoV-2,vaccine efficacy,variants of concern (VOCs)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined